Levi & Korsinsky, LLP announces that a VERU class action lawsuit has been filed on behalf of investors who purchased Veru Inc. (VERU) common stock between May 11, 2022, and November 9, 2022. For more on the VERU Lawsuit please contact us today.
According to the Veru Inc. lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that:
1) the Company had withheld material adverse facts about the data from the sabizabulin Phase 3 trial and the Company’s interactions with the United States Food and Drug Administration; 2) defendants misled Veru’s shareholders to believe that the data from the sabizabulin Phase 3 trial was sufficient to support Emergency Use Authorization (“EUA”) and even the submission of a New Drug Application without any further studies; and 3) the Company’s filings concealed the true risks faced by Veru in gaining approval for its EUA request.
If you suffered a loss in Veru Inc. you have until February 6, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.